Boehringer Ingelheim and IBM bring blockchain to clinical trials
Boehringer Ingelheim and IBM Canada are using blockchain technology for the first time in a clinical trial setting to test the technology’s trial management capabilities.
Archives for February 14, 2019
Innovaderm continues use of Medrio’s EDC for dermatology trials
Innovaderm inks deal to extend its use of Medrio’s cloud-based EDC technology for early-phase dermatology clinical trials through 2023.
Smart Health Record allows patients to directly share their data
monARC Bionetworks’ Smart Health Record allows patients to directly share with researchers their data from various disparate sources – “creating a new data collaboration economy.”
Charles River to acquire Citoxlab, M&A ‘a top priority’
Charles River is set to acquire Citoxlab for €448m ($510m) in cash, a deal which would bolster the CRO’s safety assessment portfolio to support its long-term organic growth aspirations, says CEO.
SGS is conducting its first malaria human challenge trial
The malaria volunteer infection study begins this month and is being conducted at SGS’ 20-bed unit in Belgium.
Esketamine nasal spray for ‘debilitating mental illness’ recommended for approval
US FDA Psychopharmacologic Drug Advisory Committee recommends Spravato, an intranasal form of esketamine, for approval based on its favorable benefit-risk profile.